⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 13, 2013Immunological ReviewsOpen Access

Engineering T cells for cancer: our synthetic future

View Full Paper

Ask AI

Bookmark

Share

Abstract

Video podcast available Go to www.immunologicalreviews.com to watch an interview with Guest Editor Dr Carl June.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Vonderheide et al. (2013) studied this question.

synapsesocial.com/papers/6a2095891c091fe67895102f https://doi.org/10.1111/imr.12143

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of GlioblastomaOriginal Research · 2012 · 69 citations
2Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trialCohort Study · 2002 · 219 citations
3Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificityOriginal Research · 2005 · 168 citations
4Efficient Transfer of a Tumor Antigen-Reactive TCR to Human Peripheral Blood Lymphocytes Confers Anti-Tumor ReactivityIn Vitro Study · 1999 · 410 citations
5Re‐adapting T cells for cancer therapy: from mouse models to clinical trialsHuman Clinical Trial · 2013 · 82 citations